ibrutinib
janssen,abbvie
['ibru', 'lymsm', 'cll']
this should have been plenary and highlights the major bias against neg data, which can be equally practice informing! #17icml #lymsm cll12
ibrutinib vs placebo in asympt cll
- pfs benefit but no os benefit
-even placebo arm had 99% aes so many lessons learnt! 
Clinician-researcher-educator @MSKCancerCenter Tweets about #Lymphoma #CLL #GeriOnc #PRO #MedEd Proud alum @OfficialJipmer @AIIMS_ND @UpstateNews @RoswellPark